Skip to Main Content

Early signals. Smarter decisions.

STAT Trials Pulse is a real-time clinical intelligence platform that monitors disparate sources of data to surface patterns and trends that will get you ahead.

Request a demo

In the last 12 months alone, over 2.5 million changes were recorded in the U.S. clinical trials registry.

That’s an average of over 6,800 updates every day.

Trying to analyze these changes and look for outliers is a staggering undertaking — but also essential for pharmaceutical companies and investment firms seeking competitive intelligence. STAT Trials Pulse dynamically watches data from trusted sources — including press releases, the National Library of Medicine,, and scientific papers from PubMed — and delivers the information you need in one place.

STAT Trials Pulse features

Comprehensive Event Detection

Proprietary algorithms that monitor all clinical trial changes on your behalf, prioritizing and unveiling hidden patterns and insights before they become news.

Real-Time Smart Alerts

An intelligent system that notifies you in real-time of noteworthy updates to the companies and therapeutic areas you care about.

Personalized Email Briefings

A curated digest delivered to your inbox that aggregates all the important information you need in one place.

Get started now for free

Enjoy a 30-day free trial when you sign up for STAT Trials Pulse. If you like what you see, activate one of the following membership plans once your trial ends:


For individuals life sciences professionals who want to monitor drug development with the same level of sophistication as a large organization.


For groups seeking to accelerate decision making in strategy, competitive positioning and investment opportunities.

STAT x Applied XL Partnership

STAT and Applied XL have partnered to bring you Trials Pulse. Applied XL brings to the table an experienced team of computational journalists and engineers that specialize in real-time information processing. STAT builds on its track record of telling compelling stories in health and medicine, to inform their clinical trials algorithm. By combining the precision of data science with the high standards of journalism, we’ve unlocked a powerful new way to surface the most relevant updates in the clinical trials space.